Resistant to Ablation, Responsive to Hydroquinidine: Precision Medicine Guides Recovery in MEPPC Syndrome Cardiomyopathy
Journal of Arrhythmia · 2026-06 · 42 (3)
DOI: 10.1002/joa3.70318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Arrhythmia, online erschienen am 08.05.2026. Verfasst von Jonathan L Ciofani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School The University of Sydney Sydney Australia. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Sydney Medical School The University of Sydney Sydney Australia.
- Department of Cardiology Royal North Shore Hospital Sydney Australia.
- Department of Epidemiology and Biostatistics, School of Public Health Imperial College London London UK.
- Department of Cardiology Concord Repatriation General Hospital Sydney Australia.
- Faculty of Medicine, Health and Human Sciences Macquarie University Sydney Australia.
ORCID-Profile: Hariharan Raju
Zitieren
APA
Ciofani, J. L., Raju, H., & Anastasius, M. (2026). Resistant to Ablation, Responsive to Hydroquinidine: Precision Medicine Guides Recovery in MEPPC Syndrome Cardiomyopathy. Journal of Arrhythmia, 42(3). https://doi.org/10.1002/joa3.70318
Vancouver
Ciofani JL, Raju H, Anastasius M. Resistant to Ablation, Responsive to Hydroquinidine: Precision Medicine Guides Recovery in MEPPC Syndrome Cardiomyopathy. Journal of Arrhythmia. 2026;42(3). doi:10.1002/joa3.70318
BibTeX
@article{Ciofani2026,
author = {Ciofani, Jonathan L and Raju, Hariharan and Anastasius, Malcolm},
title = {Resistant to Ablation, Responsive to Hydroquinidine: Precision Medicine Guides Recovery in MEPPC Syndrome Cardiomyopathy},
journal = {Journal of Arrhythmia},
year = {2026},
volume = {42},
number = {3},
doi = {10.1002/joa3.70318}
}
EUVIMED